CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for NeoCore Technology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

NeoCore Technology Co Ltd
9F-8, No. 395,
Section 1, Linsen Road, Longshan Village
Phone: +886 37585585p:+886 37585585 TAINAN, 701  Taiwan Ticker: 41314131
Business Summary
NeoCore Technology Co Ltd is a Taiwan-based company mainly engaged in the research and development and production of biological detection chips and the trading of contact lenses of its subsidiaries, as well as the provision of related inspection and technology transfer services. The products include deoxyribonucleic acid / ribonucleic acid (DNA/RNA) sample preparation kits, polymerase chain reaction kits, rapid hybridization equipment, biochips, testing reagents, biological preparations, nucleic acid sequencing detection, biotechnology control hardware and software and related components, biomedical materials, and nutritional supplements. The products are mainly sold domestically and exported to Asia and Europe.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief R&D Officer DingmaoZhou 3/22/2023 8/2/2022
General Manager, Corporate Governance Officer WenshengJi 3/22/2023 6/15/2022
Head of Finance & Accounting WeizheLu 11/9/2022 11/9/2022
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 37 (As of 12/31/2012)
Outstanding Shares: 39,500,000 (As of 9/30/2024)
Shareholders: 7,434
Stock Exchange: TPO
Fax Number: +886 37585586


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024